share_log

Cytek Biosciences Names William McCombe Chief Financial Officer; Reaffirms 2024 Revenue Outlook Of $203M-$213M Vs $207.86M Est.

Cytek Biosciences Names William McCombe Chief Financial Officer; Reaffirms 2024 Revenue Outlook Of $203M-$213M Vs $207.86M Est.

Cytek Biosciences任命威廉·麥科姆爲首席財務官;重申2024年的收入展望爲2.03億至2.13億美元,而美國東部標準爲2.0786億美元。
Benzinga ·  03/19 08:06

Experienced executive with extensive background as CFO for global corporations across dynamic sectors

經驗豐富的高管,擁有豐富背景的跨國公司跨國公司的首席財務官

Cytek reaffirms 2024 outlook

Cytek重申2024年的展望

FREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately. McCombe brings experience as a public company CFO at both large scale, and smaller, high growth technology companies. He was CFO at Velo3D, a leader in metal 3D printing systems for the aerospace and other industries, CFO at HZO, a leader in delivering protective nano coatings for electronics, and EVP and CFO at Maxar Technologies, a multi-billion-dollar revenue satellite and space imaging company.

加利福尼亞州弗裏蒙特,2024年3月19日(GLOBE NEWSWIRE)——Cytek Biosciences, Inc.(納斯達克股票代碼:CTKB)今天宣佈,威廉(比爾)麥庫姆已被任命爲該公司的首席財務官,立即生效。McCombe擁有在大型和規模較小的高增長科技公司擔任首席財務官的經驗。他曾是航空航天和其他行業金屬3D打印系統的領導者Velo3D的首席財務官,電子產品保護性納米塗層的領導者HZO的首席財務官,以及收入數十億美元的衛星和太空成像公司Maxar Technologies的執行副總裁兼首席財務官。

McCombe has significant experience in financial management, public company reporting and operational finance, and a proven track record of driving growth and building high-performance teams. He also brings deep expertise in mergers, acquisitions, and capital markets transactions with a career of more than 20 years as an investment banker, where he was a Managing Director at Morgan Stanley and at Bank of America. McCombe earned an MBA from Columbia University, and Bachelor of Laws and Bachelor of Commerce degrees from the University of Melbourne.

McCombe在財務管理、上市公司報告和運營財務方面擁有豐富的經驗,在推動增長和建立高績效團隊方面有着良好的記錄。他還在併購、收購和資本市場交易方面擁有深厚的專業知識,擁有超過20年的投資銀行家生涯,曾在摩根士丹利和美國銀行擔任董事總經理。McCombe 擁有哥倫比亞大學工商管理碩士學位以及墨爾本大學法學學士和商學學士學位。

"Bill's wealth of experience in finance, combined with his strategic approach, expertise in public company dynamics, and transformational leadership skills, uniquely positions him to drive our corporate objectives." stated Dr. Wenbin Jiang, Cytek's Chairman and CEO. "We are confident in his ability to partner with us in steering Cytek towards sustainable growth and long-term value creation."

Cytek董事長兼首席執行官Wenbin Jiang博士表示:“比爾豐富的財務經驗,加上他的戰略方針、上市公司動態方面的專業知識和變革型領導能力,使他在推動我們實現企業目標方面處於獨特地位。”“我們相信他有能力與我們合作,引導Cytek實現可持續增長和長期價值創造。”

"Cytek is globally recognized as a leader in cell analysis solutions," said McCombe. "I am excited by the opportunity to join such an innovative company and play a meaningful role in charting the next chapter of the company's continued success. I believe there is tremendous growth potential at Cytek, and I look forward to the journey ahead."

麥科姆說:“Cytek被全球公認爲細胞分析解決方案的領導者。”“有機會加入這樣一家創新的公司,在開啓公司持續成功的下一章方面發揮有意義的作用,我感到非常興奮。我相信Cytek有巨大的增長潛力,我期待着未來的旅程。”

As CFO, McCombe will lead Cytek's global finance organization and financial activities including accounting and controllership, financial planning and analysis, tax, investor relations, internal audit, mergers and acquisitions, and treasury. McCombe will be based in Cytek's Fremont, California headquarters.

作爲首席財務官,McCombe將領導Cytek的全球金融組織和財務活動,包括會計和控制、財務規劃和分析、稅務、投資者關係、內部審計、併購和財務。McCombe將設在Cytek位於加利福尼亞州弗裏蒙特的總部。

McCombe succeeds Patrik Jeanmonod, who has been appointed as the company's head of corporate development analytics. Jeanmonod served as Cytek's chief financial officer since 2018.

麥庫姆接替了被任命爲公司企業發展分析主管的帕特里克·瓊莫諾德。珍莫諾德自2018年起擔任Cytek的首席財務官。

Jiang expressed, "I would like to thank Patrik for what he has accomplished at Cytek. He has played an instrumental role in the growth of Cytek during a transformational period, developing the financial strategy and planning behind multiple transactions and programs as well as key finance initiatives. We are thankful for Patrik's tremendous contributions to Cytek over the years and we look forward to his continued contributions under his new role."

江澤民表示:“我要感謝帕特里克在Cytek所取得的成就。在轉型時期,他在Cytek的增長中發揮了重要作用,制定了多筆交易和計劃背後的財務戰略和規劃,以及關鍵的財務舉措。我們感謝Patrik多年來對Cytek的巨大貢獻,我們期待他在新職位上繼續做出貢獻。”

2024 Outlook Reaffirmed

重申 2024 年展望

Cytek also reaffirms its previously stated full year 2024 revenue guidance of $203 million to $213 million, representing growth of 5% to 10% over Cytek's 2023 total revenue, and its expectation of positive net income for the year ended December 31, 2024, assuming no change in currency exchange rates.

Cytek還重申了其先前公佈的2024年全年收入預期爲2.03億美元至2.13億美元,比Cytek2023年的總收入增長了5%至10%,並預計假設貨幣匯率沒有變化,截至2024年12月31日的年度淨收入將爲正數。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論